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Abstract Liquid-phase electrophoresis either in the classical
capillary format or miniaturized (chip CE) is a valuable tool
for quality control of virus preparations and for targeting ques-
tions related to conformational changes of viruses during infec-
tion. We present an in vitro assay to follow the release of the
RNA genome from a human rhinovirus (common cold virus)
by using a molecular beacon (MB) and chip CE. The MB, a
probe that becomes fluorescent upon hybridization to a com-
plementary sequence, was designed to bind close to the 3′ end
of the viral genome. Addition of Trolox (6-hydroxy-2,5,7,8-
tetramethylchroman-2-carboxylic acid), a well-known additive
for reduction of bleaching and blinking of fluorophores in fluo-
rescence microscopy, to the background electrolyte increased
the sensitivity of our chip CE set-up. Hence, a fast, sensitive and
straightforward method for the detection of viral RNA is intro-
duced. Additionally, challenges of our assay will be discussed.
In particular, we found that (i) desalting of virus preparations
prior to analysis increased the recorded signal and (ii) the MB–
RNA complex signal decreased with the time of virus storage at
−70 °C. This suggests that 3′-proximal sequences of the viral
RNA, if not the whole genome, underwent degradation during
storage and/or freezing and thawing. In summary, we demon-
strate, for two independent virus batches, that chip electropho-
resis can be used to monitor MB hybridization to RNA released
upon incubation of the native virus at 56 °C.
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Introduction
Human rhinoviruses (HRVs) are non-enveloped, icosahedral
particles of approx. 30 nm diameter [1, 2]. They are composed
of four viral proteins (VP1–VP4), 60 copies each, forming the
virus capsid, and a single-stranded, positive sense RNA ge-
nome of approx. 7.1 kb covalently linked to the approx. 20
amino acid residue peptide VPg at the 5′ end. The 3′ end
carries a poly-(A) tail [3]. To date, more than 160 serotypes
have been characterized with respect to their genome se-
quence. On top of the phylogenetic classification into species
A, B and C, the first two have also been divided into a minor
and a major receptor group [4]. Minor group viruses bind
members of the low density lipoprotein receptor (LDLR) fam-
ily and major group viruses bind intercellular adhesion mole-
cule 1 (ICAM1) for cell entry. In the current work HRV sero-
type 2 (HRV-A2), a minor group prototype strain, was used.
Upon binding its receptor on the plasma membrane of the
host cell, HRV-A2 is taken up into endosomes where the acid-
ic pH induces structural changes culminating in the release of
the viral RNA genome that is supposedly shuttled across the
endosomal membrane into the cytosol in a process termed
virus uncoating. There, it is translated into a polyprotein that
undergoes proteolytic cleavages resulting in the structural and
the non-structural proteins responsible for replication [4].
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Subviral particles in which the RNA genome is prepared for
release from the protective, proteinaceous viral shell can also
be obtained in vitro and have been extensively characterized
[5, 6]; in the process of virus uncoating native virions (com-
posed of VP1 through VP4 and RNA/VPg and sedimenting at
150S) first release VP4 and expose amino-terminal sequences
of VP1. Resulting subviral A particles composed of VP1
through VP3 and RNA/VPg sediment at 135S. In a second
step, the viral RNA (with the attached VPg) is released and
empty capsids (particles sedimenting at 80S) are obtained [5].
In vitro, the alteration of HRV-A2 can either be triggered by
acidification (pH ≤5.8), which mimics the in vivo situation in
endosomes, or by heating (≥10min to ≥56 °C) [7]. Depending
on the concentration of divalent cations, subviral A particles
or empty viral capsids are formed [8, 9]. Several orthogonal
analytical methods like sucrose density centrifugation (e.g.
ref. [5]), transmission electron microscopy [10], nano
electrospray gas-phase electrophoretic mobility molecular
analysis (nES GEMMA) [2, 11] and capillary electrophoresis
(CE) [7, 8, 12, 13] have been employed in their characteriza-
tion. Fluorescence (FL) labelling of the virus capsid with N-
hydroxysuccinimide-activated dyes targeting primary amines
i.e. mainly lysine residues on the virus surface [14] or non-
covalent labelling of the RNA genome [15] or both [16]
allowed detection of virus particles with high sensitivity.
Furthermore, in a series of publications we reported the
electrophoretic analysis of fluorescently labelled HRV-A2 in
the chip format [17, 18]. We employed a commercially avail-
able instrument (Agilent 2100 Bioanalyzer) equipped with
simultaneous FL detection at two wavelengths (λex/em=470/
525 and 635/685 nm, respectively) and chips from soda-lime
glass in the absence of any sieving material and in the pres-
ence of electroosmosis. Other than classical CE in the capil-
lary format, chip electrophoresis allowed analysis within less
than 2 min (including electrophoretic sample injection).
Additionally, electrophoresis of virions in the capillary format
required the presence of detergents to avoid unreproducible
spikes from particle aggregation [13]. Upon application of
chips for electrophoresis owing to (i) differences in the
supporting material (soda-lime glass instead of fused silica)
and (ii) the short separation distance, as well as (iii) the FL
labelling of virus particles, electrophoresis of virions in the
absence of detergents could be achieved. This was a necessary
prerequisite to target processes occurring early in infection by
using an in vitro model in which the inner endosomal mem-
brane was mimicked by the lipid membrane of liposomes
(vesicles consisting of a lipid bilayer enclosing an aqueous
lumen). The possibility (i) to follow the attachment of virions
to liposomes [19, 20] and (ii) to detect changes in liposome
membrane permeability upon virus uncoating [21, 22] by
means of chip electrophoresis have been demonstrated. On
the other hand, transfer of the viral RNA genome through this
vesicle membrane was assessed via encapsulation of reverse
transcriptase in the lumen of liposomes. The released viral
RNA served as a template for cDNA synthesis inside vesicles
followed by subsequent amplification by PCR and detection
via agarose gel electrophoresis [22].
In the current manuscript, we now demonstrate that the
combination of molecular beacons (MBs) with chip electro-
phoresis is also suitable to assess the in vitro release of viral
RNA into an aqueous buffer (see Electronic Supplementary
Material (ESM) Fig. S1 for a schematic of the study outline).
MBs, short, single-stranded oligonucleotides, carry a
fluorophore/quencher pair at their respective ends. Under
favourable conditions (e.g. the ionic strength, I, of a corre-
sponding buffer), sequences at the 3′ and 5′ ends of the MB
form a short helix structure (stem) leading to spatial proximity
between the fluorophore/quencher pair (closed hairpin) and no
FL is recorded. Hybridization of nucleotides not involved in
stem formation (i.e. the loop) to a complementary target se-
quence results in loss of the stem helix structure and hence to
an increase in FL (open hairpin) [23].
To date several publications describe the application of
MBs for virus genome detection e.g. as FL probes in living
cells [24, 25]. Su et al. [26] recently introduced a microfluidic
approach to detect fish pathogens via MBs and magnetic
beads. In the current manuscript we demonstrate the specific
detection of viral RNA by a fast and easy-to-handle chip elec-
trophoresis method. With this we set the stage for a more
detailed analysis of the release of the HRV-A2 RNA genome
from the protective virus capsid by usingMBs.We expect this
analytical method to help in obtaining a more detailed view of
how the viral RNA genome that is tightly packed inside the
viral shell passes through a small orifice in the subviral capsid
during infection. The current hypothesis suggests RNA re-
lease in the form of a completely unfolded single strand im-
plying that nucleotide sequences along the genome must be-
come available for hybridization in a time-dependent manner
from the 3′ towards the 5′ end; by using a set of suitable MBs,
such analyses might become possible with the methodology
described in the present report.
Materials and methods
Chemicals and reagents
Boric acid and DMSO (both pro analysis) were obtained from
Fluka (Steinheim, Germany) and sodium hydroxide (≥99 %)
from Merck (Darmstadt, Germany). Atto 488, Atto 495 and
Atto 633 were from Atto Tec (Siegen, Germany). The three indi-
vidual fluorophore molecules were dissolved in DMSO (at 2.5,
3.3 and 2.5 mM, respectively) and further diluted as described
below. Trolox (6-hydroxy-2,5,7,8-tetramethylchroman-2-carbox-
ylic acid) and Benzonase nuclease (ultrapure grade) were pur-
chased from Sigma Aldrich (Steinheim, Germany). Water
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(18.2MΩ cm resistivity at 25 °C) was from aMillipore (Billerica,
MA, USA) apparatus.
Biological material
HRV-A2 was prepared and its infectivity was assessed as de-
scribed [27]. The 50% tissue culture infectious dose (TCID50/
mL) of preparations was typically between 1010 and 1011 in-
fectious units per mL (refer to ESM Fig. S2 summarizing the
data of the virus preparations used). The concentration of virus
particles was obtained from nES GEMMA measurements [2,
11, 28] yielding virus peak heights. Comparison of these
values to the nES GEMMA peak height obtained for an
HRV-A2 preparation whose concentration had previously
been measured by CE [27] and taking sample dilution into
account enabled us to calculate virus concentrations of all
employed batches. It is of note that lipase-treated virus prep-
arations [11] still contained low but detectable amounts of so
far unidentified contaminating material. Therefore, it has to be
concluded that the purity of HRV-A2 preparations is depen-
dent (i) on the original amount of this contaminating material
(prior to lipase digestion) and (ii) on the activity of lipase
which differs between enzyme batches. HRV-A2 quality con-
trol either via nES GEMMA or TEM [27] thus appears to be
necessary to check whether the purity of a given preparation is
sufficient for a particular experiment. HRV-B14, another rhi-
novirus strain, was prepared as above and employed at
2 mg/ml (3.65×1011 TCID50/mL) in 50 mM Tris, pH 7.4 as
a negative control for the specificity of the MB.
Oligonucleotides were obtained from Integrated DNA
Technologies (Leuven, Belgium). The MB (Atto 633 -
tcgcaCAAAAGCAAATCATACGGAGGGATGcga - Iowa
Black RQ-Sp quencher) targets a region close to the 3′ end
of the HRV-A2 genome (nucleotides 7017–7041, see ESM
Fig. S3 for the position of complementarity on the viral
RNA genome [29]). Uppercase letters are bases complemen-
tary to the viral RNA. MB nucleotides were modified with
locked nucleotides (LNAs, in bold and italics). Care was
exercised to exclude intramolecular recognition of LNAs.
An oligonucleotide complementary to the MB (with eight
additional nucleotides identical to the viral genome at each
end) was employed as positive, single-stranded DNA
(ssDNA) control for MB binding. An oligonucleotide of the
same length but with a sequence of a different region of the
viral RNA was employed as a negative ssDNA control.
ssDNA controls did not contain LNA. The MB and controls
were purified by HPLC and lyophilised. They were dissolved
in 2 mM ammonium acetate, pH 7.2 to yield 0.5 mM stock
solutions (based on the amounts specified by the manufactur-
er). Aliquots were kept at −20 °C. The MB stock solution was
subsequently diluted for preparation of samples used in exper-
iments as specified below. It is of note that the MB in the
presence of Trolox suffered an alteration over time that
impacted on its FL output. The long-term storage of the MB
in background electrolyte (BGE) solutions containing Trolox
was therefore avoided (unpublished data). When contact of
MB with Trolox was limited to a sample preparation step on
the day of measurement, no such alteration was observed.
As an additional control to exclude unspecific binding, MB
was incubated with RNAs of irrelevant sequence (RNA ladder
from Agilent Technologies, Waldbronn, Germany, a mixture
of six RNAs of lengths between 0.2 and 6 kb at a total con-
centration of 150 ng/μL in 0.1 mM EDTA). ESM Fig. S4
depicts the corresponding electropherogram for such a ladder
sample obtained from a standard chip gel electrophoresis set-
up.
Instrumentation
Chip electrophoresis was carried out on an Agilent 2100
Bioanalyzer instrument in the presence of electroosmosis
employing commercially available, single-use chips [17, 18].
Modifications of the script (software of the instrument)
allowed electrophoresis of samples at ambient temperature
(typically T= 22.5 ± 0.3 °C). Sodium borate, pH 8.5, with
and without Trolox as indicated (total ionic strength, I, was
kept constant at approx. 40 mM) was employed as BGE and
sample buffer (SB). Sodium borate was filtered (0.2 μm pore
size, surfactant-free cellulose acetate membranes from
Sartorius, Göttingen, Germany). Analyte detection was simul-
taneously at two wavelengths (λex/em = 470/525 and 635/
685 nm). The instrument optics was adjusted to the position
of a respective single-use chip inside the instrument after elec-
trophoretic flushing of the separation channel with 100 nM
Atto 633 in BGE. Subsequently, the fluorophore was removed
from the separation channel via electrophoresis.
Sample preparation
Samples contained MB at 40 nM as well as Atto 488 (2.5 μM)
and Atto 495 (3.3 μM) as internal standards. Positive control
ssDNA target concentrations of up to 400 nM and negative con-
trol ssDNA target concentrations of 200 nM were employed as
indicated in the respective figures. When RNA ladder was used
as negative control, 6 ng/μL was employed (yielding a compa-
rable molar concentration of the RNA and DNA controls).
Samples were incubated at 30 °C for 30 min at 800 rpm
employing an Eppendorf Thermomixer instrument to check
for MB reactivity employing control oligonucleotides.
Subsequently, samples were cooled and stored on ice until anal-
ysis on the same day. For detection of the RNA released from
HRV-A2, the control nucleotides were substituted by HRV-A2.
The virus was either directly diluted in BGE or employed after
additional removal of lowmolecular weight components follow-
ed by such a dilution step. In both cases, the dilution factor of
virus stock was 1:15 (v/v). Removal of low molecular weight
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sample components was carried out as described elsewhere [30]
employing polyethersulfone membrane filters with a 10-kDa
molecular weight cutoff (VWR, Vienna, Austria). The final virus
concentration was around 80 nMwith an infectivity of 2.8×1010
TCID50/mL (overall dilution of HRV-A2 preparation A of 1:16.7
(v/v); for a list of all employed HRV-A2 preparations refer to
ESM Fig. S2). Samples were heated for 15 min to 56 °C
(800 rpm, Eppendorf Thermomixer) to trigger RNA release.
Subsequently, samples were cooled on ice to allow forMB bind-
ing and subjected to chip electrophoresis. Negative controls (i)
omitted the heating step or (ii) replaced HRV-A2 by HRV-B14,
whose RNA sequence has no regions complementary to theMB.
(iii) The impact of 15min heating to 56 °C onMBswas assessed,
too.
Data evaluation
Raw data were exported from the Agilent 2100 Bioanalyzer
software. For inter- and intrachip comparability, electrophero-
grams were adjusted with respect to analyte migration accord-
ing to Reijenga et al. [31] and to the signal heights of the
internal standards as detected with the blue LED of the instru-
ment (see BResults and discussion^). The area of the recorded
FL signals was obtained by fitting Gaussian-shaped peaks to
the data (OriginPro 9.1.0; see ESM Fig. S5 for an exemplary
electropherogram).
Results and discussion
To generate a specific fluorescence signal the closed hairpin of
the MBmust open, which needs to be triggered via binding of
its loop sequence to the complementary sequence of a target.
Unfolding without hybridization, which might occur at low I
or elevated temperature, results in a false positive signal.
Therefore, orienting experiments were conducted with various
MBs (same stem, different loop) to investigate the dependence
of unfolding on I of the BGE (not shown). As expected, in-
crease of I led to a reduction of the observed electroosmotic
flow as well as to a higher proportion of the MB in its closed
hairpin conformation, i.e. less FL was recorded. The maximal
possible FL gain under the finally chosen I conditions was
determined via nuclease digestion of the MB, which leads to
its complete dequenching. Addition of divalent cations (e.g.
Mg2+) known to stabilize the MB stem was omitted as these
had been found to stabilize viral uncoating intermediates [9].
Chip electrophoresis of MBs
We carried out chip CE measurements in sodium borate,
I=40 mM (pH 8.5). For intra- and interchip comparison of the
electropherograms, we included two additional fluorophores in
samples similar to Bidulock and colleagues, who used caesium
and lithium chloride as internal standards in sodium chloride
analysis on home-made chips [32]. In our case, Atto 488 and
Atto 495 gave rise to FL signals detectable with the blue LED of
the applied instrument and did not interfere with analyte signals
detected at λex/em=635/685 nm (see ESM Fig. S6A). In the
specified BGE, Atto 495 is zwitterionic and migrates with the
electroosmotic flow (EOF), whereas Atto 488 is negatively
charged (the structure of dyes is available from the homepage
of the manufacturing company). Migration of both peaks of the
internal standards is such that electropherogram normalization,
as described by Reijenga and colleagues [31], is feasible and
slight changes in the EOF can be corrected. As all samples
included the same amount of both dyes, we were also able to
correct for slight changes in FL intensities. An intensity correc-
tion factor for each of the two internal FL standards was calcu-
lated separately and the average of these two numbers was
employed to finally correct the FL intensity of a corresponding
electropherogram. ESM Figs. S6B and C demonstrate the utility
of this approach for correction of the blue traces of several elec-
tropherograms obtained from different chips. Upon normaliza-
tion of both axes the signals were comparable.
Although we expected a completely closed state of the
MBs under the given electrophoresis conditions and in the
absence of a target molecule, our analyses showed that the
MB exhibited residual FL in the absence of cognate oligonu-
cleotides or viral RNA targets (ESM Fig. S7). However, com-
pared to the high signal obtained after digestion with
Benzonase this background was found to be negligible (an
approx. 25-fold increase of FL was recorded upon
Benzonase treatment). Therefore, we were indeed able to set
the stage for our intended in vitro viral RNA release detection
method by slight advancements of chip CE in comparison to
our originally published set-up [17, 18] i.e. by inclusion of
two internal standards as well as by choosing conditions
where the majority of the MB is in its closed hairpin state
(i.e. by adjustment of I of the BGE). Additionally, we modi-
fied the software of the instrument (script) to allow electro-
phoretic separations at ambient temperature (T = 22.5
±0.3 °C).
Impact of BGE additives on FL response of MB
Subsequent experiments targeted the MB’s reactivity in
the presence of the respective positive control ssDNA
oligonucleotide. With increasing concentration of this
oligonucleotide an increase of FL was recorded
(Fig. 1). No such increase was detected with the nega-
tive control oligonucleotide or with the RNA ladder
(ESM Fig. S8A, B).
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Several compounds reduce blinking and photobleaching of
fluorophores [33] in FL microscopy. In our case Trolox (6-
hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid) at
10 mM concentration in the BGE and SB increased the FL
signal by approximately two- to threefold (Fig. 2). Fitting
Gaussians to the electropherogram peaks yielded a linear cor-
relation between the concentration of the positive control oli-
gonucleotide and the area of the FL peak. In the presence of
10 mM Trolox, the FL signal equalled 0.282 times the con-
centration of the positive control oligonucleotide (in
nanomoles per litre). In the absence of Trolox the slope of
the linear correlation dropped to 0.108. Higher concentrations
were not tested because of the limited solubility of Trolox
(around 3 mg/mL which corresponds to approx. 12 mM in
phosphate buffered saline, pH 7.2; www.scbt.com/datasheet-
200810-trolox.html). Additive concentrations close to its
solubility limit might lead to clogging of the chip channels.
Use of ascorbic acid as an alternative additive (up to 6 mM)
failed to increase the FL yield (data not shown).
Detecting RNA release via MBs and chip electrophoresis
Following our experiments with control oligonucleotides we
mixed MB with HRV-A2, triggered virus uncoating via
heating for 15 min to 56 °C, and carried out chip CE as above.
Desalting of HRV-A2 preparations was beneficial for the FL
signal obtained from MB binding the viral RNA possibly
because uncoating might have been reduced owing to the
stabilizing effect of Mg2+ and other divalent cations present
in the HRV-A2 stock solution [9]. After this buffer exchange
we observed clear and specific signals for the MB–RNA com-
plex (compare Fig. 3a without HRV-A2 desalting prior virus
uncoating to Fig. 3b where HRV-A2 desalting had been car-
ried out before initiating viral RNA release at 56 °C). The test
with MB alone (in the absence of virus) showed only a low
response to sample heating to 56 °C indicating that it folded




















Fig. 1 Chip CE results for MB binding to positive control ssDNA
oligonucleotides employed at indicated concentrations. With increasing
concentrations of the control oligonucleotide an increase of the FL signal
is observed in the electropherograms. Sodium borate, pH 8.5 (I= 40mM)
without any additives was employed as SB and BGE. Data was aligned as
described in the text
























Adj. R2: 0.984 
Fig. 2 Addition of 10 mM Trolox to the BGE (I constant at 40 mM)
resulted in a two- to threefold increase of FL signals obtained for the MB/
positive control ssDNA oligonucleotide complex as a result of reduced
photobleaching and blinking. Values of symmetric Gaussian peaks fitted
to electropherograms were taken for calculation. The number of repeats
per data point is indicated in the figure, standard deviation values are
shown. Data points are approximated via linear fits
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Fig. 3 Detection of free viral RNA by using our chip CE set-up. RNA
release was triggered through heating of the virus preparation (15 min to
56 °C). As a negative control, the sample was kept in ice and the viral
RNA remains inside the protein shell and inaccessible to the MB. Buffer
exchange of the HRV-A2 batch was found to strongly increase the signal
of the viral RNA (compare a, which is the result without buffer exchange,
and b, which is the result including a sample buffer exchange step).
Sodium borate, pH 8.5 including 10 mM Trolox (I = 40 mM) was
employed as SB and BGE. Data was aligned as described in the text
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back on cooling (ESM Fig. S8C). Likewise, no reactivity of
the MB with RNA from HRV-B14 was recorded indicating
that the obtained MB/RNA signal was specific (ESM
Fig. S8D). RNase activity after release of the viral genome
slightly impacted the obtained MB–RNA complex signal.
Given samples were stored on ice as well as under light pro-
tection and measurements were carried out within a few hours
after sample preparation areas recorded for the complex were
found to be within approx. 10% of an average (ESM Fig. S9).
Challenges of the experimental set-up
Having demonstrated the applicability of our set-up to quali-
tatively follow the release of HRV-A2 RNA employing an
MB and chip CE, we were interested in the quantification of
the obtained FL signals. However, measurements of identical-
ly prepared samples showed a significant decline of the MB–
RNA signal over time of storage at −70 °C and the numbers of
freezing and thawing cycles of the virus stock solution
(Fig. 4a; note that samples were prepared freshly for each
experiment). It is important to mention that a decline of infec-
tivity by as much as one log TCID50/mL even during storage
at −80 °C for several weeks was frequently observed.
However, fluorescence of the MB measured on incubation
with native HRV-A2 whose RNA is inaccessible (Fig. 4b)
did not alter in FL over time. This makes it unlikely (i) that
the MB interacts with virus and/or virus aggregates, which
might reduce the concentration of free MB in solution and
(ii) that the MB is degraded. Instead we assume that repeated
freezing/thawing of the virus stock solution impacted on the
signal as a result of the viral RNA being degraded.
Breathing, i.e. transient exposure of capsid-internal N-ter-
minal sequences, of VP1 and VP4 was reported for picorna-
viruses [15] and similar dynamics of virus capsid components
have been observed for hepatitis B virus capsids [34]. These
transient rearrangements of the capsid proteins might account
for the RNA becoming accessible for RNases, especially dur-
ing freezing and thawing. In this context it is of note that
Gauntt had observed fragmentation of the RNA in virions of
another serotype [35].
Material apparently released from HRV-A2 later in the ex-
perimental series (i.e. after virus storage at −70 °C and repeat-
ed freezing/thawing leading to viral RNA degradation) result-
ed in quenching of overall FL. Hence, special care has to be
exercised with virus storage and freezing/thawing. Also, in-
clusion of RNase inhibitors in samples and stocks might be
beneficial to avoid eventual degradation of the viral RNA via
RNases that might gain access during temporary opening of
pores given that an impact of these additional components on
chip CE can be excluded.
On the basis of the linear correlation between the concen-
tration of the control oligonucleotide and FL, we calculated
the amount of viral RNA that was released on heating. This
yielded 43 nM for the most prominent MB–RNA complex
signal (at day 177 after HRV-A2 preparation; Fig. 4a). When
the virus was then frozen and thawed the RNA concentration
was found to be decreased, which is in line with the well-
known natural decay of viruses.
Analysis of HRV-A2 preparations other than A led to sim-
ilar results (see ESM Fig. S2 for an overview of virus prepa-
rations) when the TCID50/mL values and purities were com-
parable, as in preparation D. In the case of low virus concen-
trations (e.g. batch B, see ESM S1) or highly impure virus
preparations (e.g. batch C, see ESM S1), no MB–RNA com-
plex could be detected (Fig. 5a–d for indicated HRV-A2 prep-
arations). Batch C showed considerable amounts of the previ-
ously described contaminant as well as a protein impurity,






























Fig. 4 Decline of the MB/RNA signal in the course of chip CE
experiments over time. Viral RNA release experiments as presented in
Fig. 3 were repeated at the indicated times (days) after preparation of the
original HRV-A2 batch. Samples were prepared freshly from an HRV-A2
stock for each time point. A decline in the FL signal for the MB/RNA
signal (a) was observed over time which was ascribed to degradation of
the viral RNA genome. No significant decline is observed for the negative
control electropherograms for the MB in the presence of HRV-A2 but
without triggering of viral RNA release (b)
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possibly ferritin, as inferred from gas-phase electrophoresis
(nES GEMMA).
Conclusions
The major aim of this study was the development of a fast,
sensitive and easy-to-handle analytical method to detect viral
RNA by using an MB and chip CE to set the stage for further
investigation of the mode of release of the RNA genome of a
human rhinovirus. Intra- and interchip comparison of results
by using internal standards was good (analytes were detected
with the second wavelength of the instrument without inter-
ference from internal standard signals). Addition of Trolox to
the BGE increased the FL signals substantially. Our results
demonstrate that the release of the viral RNA genome from
the viral capsid can indeed be monitored via the combination
of anMB and chip CE. However, during our investigations we
noted a significant decrease of the signal measured with the
MB over time of storage at −70 °C and repeated freezing/
thawing, which we attributed to degradation of the viral
RNA genome. Nevertheless, given that an HRV-A2 prepara-
tion was of sufficiently high purity and the virus concentration
was in the range of at least 1010 TCID50 in the final sample,
results between preparation batches were very similar. Future
work might substantially lower this detection threshold and
will also allow the extension of our presented in vitro set-up to
the analysis of other viruses.
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Fig. 5 Chip CE results for
different HRV-A2 batches a–d.
(see ESM Fig. S2). Virus stock
solutions were subjected to buffer
exchange. Depending on the
quality of the preparation (purity
and infectivity), a signal for the
MB–RNA complex is obtained.
Conditions as noted for Fig. 3. No
RNA release triggered via sample
heating, dashed line; RNA release
triggered by sample heating for
15 min to 56 °C, solid line
Chip CE following HRV-A2 RNA relaese via MB 4215
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